Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831046 · ClinicalTrials.gov registry record · NA
Emergency Department Re-evaluation Software Pilot Study
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05831046: Completed NA study, sponsored by Duke University.
NCT05831046 is a NA study that has completed, run by Duke University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05831046, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a research study to determine a method in improving emergency department waiting room care by using new software program.
Primary Outcome
The primary objective of this study is to determine efficacy of the designed software, which focuses on the identification and disposition of patients who would otherwise become left before treatment complete (LBTC) patients in the ED waiting room.
Interventions
- OTHER ED management software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2025-06-10 |
| Phase | NA |
What the finished NCT05831046 record still lists
NCT05831046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ED management software is the first listed.
NCT05831046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05831046 about?
NCT05831046 is a clinical study titled "Emergency Department Re-evaluation Software Pilot Study". This is a research study to determine a method in improving emergency department waiting room care by using new software program.
What is the current status of trial NCT05831046?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-10-03. Estimated completion is 2025-06-10.
What interventions are being tested in trial NCT05831046?
The interventions under investigation include: ED management software (OTHER).
Who is sponsoring clinical trial NCT05831046?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05831046's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI